Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
---|
05/22/2009 | WO2009062988A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use |
05/22/2009 | WO2009062987A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use |
05/22/2009 | WO2009062676A2 Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
05/22/2009 | WO2009062308A1 Inhibitors of human immunodeficiency virus replication |
05/22/2009 | WO2009045489A3 Process for the synthesis of cmhtp, a paliperidone intermediate |
05/22/2009 | WO2009034028A3 Novel compounds |
05/22/2009 | WO2009023299A3 Anti-angiogenic agents and methods of use |
05/22/2009 | WO2008136815A3 5, 6-ring annulated indole derivatives and use thereof |
05/22/2009 | CA2705752A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use |
05/22/2009 | CA2705513A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use |
05/22/2009 | CA2705452A1 Mapk/erk kinase inhibitors |
05/22/2009 | CA2705372A1 Preventing or ameliorating agent for skin psoriasis |
05/22/2009 | CA2705338A1 Inhibitors of human immunodeficiency virus replication |
05/22/2009 | CA2704628A1 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
05/22/2009 | CA2704599A1 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors |
05/22/2009 | CA2704454A1 Enantiomerically enriched imidazoazepinone compounds |
05/22/2009 | CA2704436A1 Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
05/22/2009 | CA2703220A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
05/21/2009 | US20090131673 Electroluminescent Device |
05/21/2009 | US20090131501 Alzheimer's disease; administering orally (+) phenserine; phenserine tartrate; racemic or enantiomerically pure; not toxic in a wide range of dosages |
05/21/2009 | US20090131468 Bis-(Sulfonylamino) Derivatives in Therapy 065 |
05/21/2009 | US20090131467 Heterocycle Compound, and Production Process and Application Thereof |
05/21/2009 | US20090131456 Caspase inhibitors and uses thereof |
05/21/2009 | US20090131444 Aminopiperidine Quinolines and Their Azaisosteric Analogues with Antibacterial Activity |
05/21/2009 | US20090131435 Heterocyclic inhibitors of mek and methods of use |
05/21/2009 | US20090131431 Pyrazolo[3,4-b]pyridine compounds, and their use as a PDE4 inhibitors |
05/21/2009 | US20090131430 Pyrido'2,3-dipyrimidines as anti-inflammatory agents |
05/21/2009 | US20090131423 Tyrosine Kinase Inhibitors |
05/21/2009 | US20090131418 Spiroazacyclic compounds as monoamine receptor modulators |
05/21/2009 | US20090131414 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for treating hepatitis c |
05/21/2009 | US20090131290 Acridan derivatives as antioxidants |
05/21/2009 | US20090130097 Quinazolinone Compounds and Methods of Use Thereof |
05/20/2009 | EP2060572A1 Pyrazolopyridine derivative and phosphodiesterase (pde) inhibitor containing the same as active ingredient |
05/20/2009 | EP2060570A2 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors |
05/20/2009 | EP2060557A1 Intermediate compounds useful to prepare dolasetron |
05/20/2009 | EP2059519A2 Nitrogen-containing heterocyclic compounds and methods of use thereof |
05/20/2009 | EP1565467B1 Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same |
05/20/2009 | CN101437822A Compounds and compositions as protein kinase inhibitors |
05/20/2009 | CN101437821A Hydrochloride salts of 8-[{1-(3,5-bis-(trifluoromethyl) phenyl) -ethoxy}-methyl] -8-phenyl-1,7-diaza-spiro[4.5] decan-2-one and preparation process therefor |
05/20/2009 | CN101437820A Heterobicyclic pyrazole compounds and methods of use |
05/20/2009 | CN101437819A Pyridopyrazines and derivatives thereof as ALK and c-MET inhibitors |
05/20/2009 | CN101437818A Novel dual action receptors antagonists (DARA) at the AT1 and ETA receptors |
05/20/2009 | CN101437816A 2-aminopyridine analogs as glucokinase activators |
05/20/2009 | CN101437803A Dibenzyl amine derivatives as CETP inhibitors |
05/20/2009 | CN101437512A Glucokinase activators |
05/20/2009 | CN101434604A Condensed n-heterocyclic compounds and their use as CRF receptor antagonists |
05/20/2009 | CN101433565A Total alkaloid extract of seeds of harmel genus and effective monomer component thereof, and preparation and use thereof |
05/20/2009 | CN100488952C 5-phenyl pyridine, its preparation method and intermediate product and uses in controlling harmful fungus |
05/20/2009 | CN100488950C Use of chemotherapeutic agents |
05/20/2009 | CN100488923C Double-loop coil organic compounds and electric-field luminescent devices |
05/19/2009 | US7534897 Indole arylsulfonaimide compounds exhibiting PGD 2 receptor antagonism |
05/19/2009 | US7534800 pyrrolo[2,3-b]pyridine derivatives; treatment of neurodegenerative disorders related to apoptosis and/or inflammation; compound prepared by condensation, halogenation, hydrogenation, using silan protected drivatives |
05/19/2009 | US7534797 6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors |
05/19/2009 | US7534793 (R)-2-{4-[(1H-Indol-2-ylmethyl)-amino]-piperidin-1-yl}-1-(6-methoxyquinolin-4-yl)-ethanol; effective against both gramnegative and grampositive bacteria |
05/19/2009 | US7534784 ligands for Calcitonin gene related peptide; azepinone ligands; migranes; N-[5-(2,3-Difluorophenyl)-1-(2-methoxyethyl)-2-oxopiperidin-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide |
05/19/2009 | CA2498047C Novel imidazole compounds as transforming growth factor (tgf) inhibitors |
05/19/2009 | CA2336634C Antiviral macrocyclic compounds |
05/19/2009 | CA2230931C 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency |
05/14/2009 | WO2009062059A2 Isomeric purinones and 1h-imidazopyridinones as pkc-theta inhibitors |
05/14/2009 | WO2009061597A1 Compounds for inhibiting ksp kinesin activity |
05/14/2009 | WO2009061596A1 Compounds for inhibiting ksp kinesin activity |
05/14/2009 | WO2009060779A1 Organic electroluminescent device material, organic electroluminescent device, display device and illuminating device |
05/14/2009 | WO2009060757A1 Organic electroluminescent device, display device and illuminating device |
05/14/2009 | WO2009060742A1 Organic electroluminescent device, display device, and illuminating device |
05/14/2009 | WO2009060297A2 An improved process for the preparation of paliperidone and its intermediates |
05/14/2009 | WO2009059666A1 7-azaindole derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
05/14/2009 | WO2008074803A8 4-benzyl-l ( 2h) -phthalazinones as h1 receptor antagonists |
05/14/2009 | WO2008060487A8 Polymorphs of nicotinic intermediates |
05/14/2009 | WO2007067711A3 Certain chemical entities, compositions, and methods for modulating trpv1 |
05/14/2009 | US20090124807 2-(2,2-Dimethoxy-ethyl)-4,4-dimethoxy-butyric acid methyl ester; for making 1H-indole-3-carboxylic acid 10-oxo-8-aza-tricyclo[5.3.1.03,8]undec-5-yl ester; antiemetic and antinausea |
05/14/2009 | US20090124806 Process for producing carboxylic acid from primary alcohol |
05/14/2009 | US20090124802 Diaryl-purines, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitor for treatment of hiv |
05/14/2009 | US20090124732 Rylene Tetracarboxylic Acid Diimides Substituted By Cyclic Amino Groups |
05/14/2009 | US20090124652 Polymorphs of 1-(2-Methylpropyl)-1H-Imidazo[4,5-C][1,5]Naphthyridin-4-Amine Ethane-Sulfonate |
05/14/2009 | US20090124649 Aza spiro alkane derivatives as inhibitors of metalloproteases |
05/14/2009 | US20090124625 Novel alkynyl derivatives as modulators of metatropic glutamate receptors |
05/14/2009 | US20090124621 Pyrazole derivatives as kinase inhibitors |
05/14/2009 | US20090124617 Quinolone derivative or salt thereof |
05/14/2009 | US20090124614 Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders |
05/14/2009 | US20090124612 Fused heterocyclic derivatives and methods of use |
05/14/2009 | US20090124611 Pyrazolopyridine-1,4-Diamines and Analogs Thereof |
05/14/2009 | US20090124609 Fused heterocyclic derivatives and methods of use |
05/14/2009 | US20090124596 Chemical Compounds 637 |
05/14/2009 | US20090124595 Mapk/erk kinase inhibitors |
05/14/2009 | US20090121623 Condensed polycyclic compound and organic light emitting device using the same |
05/14/2009 | US20090121617 Electronic devices made with electron transport and/or anti-quenching layers |
05/14/2009 | CA2704803A1 7-azaindole derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
05/14/2009 | CA2702995A1 Compounds for inhibiting ksp kinesin activity |
05/14/2009 | CA2702990A1 Compounds for inhibiting ksp kinesin activity |
05/13/2009 | EP2058310A1 Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor comprising the derivative |
05/13/2009 | EP2058309A1 Fused heterocyclic compound |
05/13/2009 | EP2057158A1 Triazole derivatives as kinase inhibitors |
05/13/2009 | EP2057157A2 2-amido-4-isoxazolyl thiazole compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
05/13/2009 | EP2057156A1 2-methylmorpholine pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors |
05/13/2009 | EP2057155A1 1h-pyrrolo[2,3-b]pyridine derivatives useful as hsp90 inhibitors |
05/13/2009 | EP2057154A1 Pyrido [2, 3-b]pyrazine derivatives useful as herbicidal compounds |
05/13/2009 | EP2057125A1 Non-nucleoside reverse transcriptase inhibitors |
05/13/2009 | EP2056822A1 Substituted pyrrolopyridines and pyrazolopyridines as kinase modulators |
05/13/2009 | EP1655028B1 Use of cyclic bioisosteres of purine system derivatives for the treatment of diseases caused by disorders of nitrergic and dopaminergic systems |
05/13/2009 | EP1587795B1 N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as cgrp-antagonists for treating a headache |